Global Bariatric Surgery Devices Market: Snapshot
Bariatric surgery is mainly used to refer to the number of weight-loss procedures. Bariatric surgical procedures are carried out for the treatment of comorbid condition which are associated with morbid obesity, which require bariatric surgery devices. Bariatric surgery involves modification in the gastrointestinal tract by which either the amount of food that the stomach can intake is restricted or the nutrients that are absorbed in the intestinal tract are restricted.
Bariatric surgery is proven to be effective over alternate treatment options for obesity associated comorbid conditions and is also viable in terms of cost and faster recovery. Moreover, increasing number of facilities that offer bariatric surgical procedures and favorable government policies for bariatric procedures to be covered by insurance are favoring the bariatric surgery devices market.
The global bariatric surgery devices market was valued at US$798.3 mn in 2016 and is expected to reach US$1,744.1 mn by 2025 rising at a CAGR of 9.3% between 2017 and 2025.
This 141 page report gives readers a comprehensive overview of the bariatric surgery devices market. Browse through 19 data tables and 63 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/bariatric-surgical-devices.html
Closure Devices Segment to Register Leading CAGR due to Popularity of Minimally Invasive Surgeries
By devices type, assisting devices and implantable devices are the segments of the market. Assisting devices are further sub-segmented into suturing devices, closure devices, stapling devices, trocars, and others. In 2016, the segment of suturing devices held the leading share of the market due to high endorsement of these devices by surgeons. On the other hand, the closure devices segment is expected to register the leading CAGR as they devices are widely used in minimally invasive surgeries that require immediate closure of very small incision done at the time of surgical procedure.
The sub-segments of implantable devices are gastric bands, electric stimulation devices, gastric balloons, and gastric emptying. Among these, gastric bands account for the leading share as they are approved by regulatory agencies and are familiar to physicians as well as patients. Nevertheless, the segment of gastric balloons is expected to register the leading CAGR due to recent approvals from FDA that have proven them to be more safe and effective over other implantable devices.
On the basis of end-user, the bariatric surgery devices market is segmented into bariatric surgery clinics, hospital pharmacies, surgical centers, and others. Among these, in 2016, bariatric surgery clinics led the market due to the increasing popularity of minimally invasive surgeries that can be performed in bariatric surgery clinics. Bariatric surgery clinics are expected to expand at the leading CAGR during the forecast period as these facilities specialize in care needed for patients before and after the procedure. Also, bariatric surgery clinics are preferred by both patients and physicians as they are well-equipped for handling adverse situations.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving bariatric surgery devices market during 2017 – 2025: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1369
Asia Pacific to Exhibit Robust Growth Rate
North America is the leading regional market for bariatric surgery devices on account of increasing incidence of obesity and associated comorbidities such as diabetes, sleep apnea predominantly in the U.S. In this region, sedentary lifestyle and increasing consumption of junk food has been the major causes of growing obesity. To address this, increasing number of individuals are undergoing bariatric surgery for weight loss to avoid further complications with the condition.
Europe is also a significant market for bariatric surgery devices due to a well-developed healthcare infrastructure and increasing spending on health and wellness.
However, Asia Pacific bariatric surgery devices market is expected to exhibit the leading growth in the forecast period. Rising economic prosperity in countries such as China and India has led to increased spending on convenience foods, leading to lifestyle diseases such as obesity. This, in turn, has led to the demand for bariatric surgical procedures.
The key players in the bariatric surgery devices market include Apollo Endosurgery Inc., Ethicon Inc., TransEnterix Inc., Agency for Medical Innovations, Cousin Biotech, EnteroMedics Inc., Medtronics Plc., Intutive Surgical Inc., Aspire Bariatrics Inc., and Mediflex Surgical Products.
Global Blood Pressure Monitoring Devices and Accessories Market: Snapshot
The global market for blood pressure monitoring devices and accessories has been registering a remarkable rise in its valuation, thanks to the increasing prevalence of hypertension, technological advancements in the design and utilities of diagnostic devices, and the rise in the funding by public and private players to create awareness about hypertension.
On the other hand, the inaccuracy in the readings, owing to obesity or any pre-existing CV disorder, and the declining prices of blood glucose monitors are likely to create restraints in the growth trajectory of this market in the near future. However, the increasing need for blood pressure kiosks at public places, such as gym, airports, and colleges, and the rise in the government funding are anticipated to boost the production volume of blood pressure monitors over the next few years.
The opportunity in the worldwide market for blood pressure monitoring devices and accessories is likely to expand at a CAGR of 7.60% between 2016 and 2024, rising significantly from a value of US$1.14 bn in 2015 to US$2.20 bn by the end of 2024.
Obtain Report Details: http://www.transparencymarketresearch.com/blood-pressure-monitoring-market.html
Hospitals to Surface as Leading End User of Blood Pressure Monitoring Devices and Accessories
Hospitals, ambulatory surgical centers, clinics, and homecare settings are the key end users of blood pressure monitoring devices and accessories across the world. The demand for these devices and accessories is greater in hospitals than other end users. Thanks to the presence of trained and qualified personnel as well as favorable reimbursement structure in various parts of the world, this scenario is anticipated to remain so over the next few years.
Homecare settings will also report a significant increase in the demand for blood pressure monitoring devices and accessories in the near future, owing to the miniaturization of the devices, and the rising demand for self-serving diagnostic equipment by consumers. In clinics, the demand for these devices will be driven by the rising base of the geriatric population and the advancements in the healthcare facilities in developing countries. Ambulatory surgical centers are expected to display a moderate demand for blood pressure monitoring devices and accessories in the years to come.
Europe to Continue Generating High Revenues
Geographically, the global blood pressure monitoring devices and accessories market is stretched across North America, Middle East and Africa, Europe, Asia Pacific, and Latin America. In terms of revenue, Europe led the overall market in 2015 with a share of more than 32%. Researchers expect this regional market to remain the leading revenue contributor to the global market over the next few years. North America, on the other hand, has been and will continue to be the key regional market for blood pressure monitoring devices and accessories in terms of volume in the near future, thanks to the rising incidence of hypertension and the increasing demand for digitally and technologically advanced diagnostic devices among consumers.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1630
Amongst others, Asia Pacific is likely to witness considerable growth in the near future, owing to the rise in the number of regional players, increasing construction of research and development facilities by established companies in the developing countries, such as Japan and China, and the shift of population towards preventive healthcare. Latin America, however, is anticipated to experience a moderate rise over the coming years. Brazil and Mexico are likely to surface as the main domestic market for blood pressure monitoring devices and accessories in this region.
Omron Healthcare Inc., Koninklijke Philips N.V., Schiller AG, American Diagnostic Corp., American Diagnostic Corp., SPENGLER, Spacelabs Healthcare, Bosch + Sohn GmbH u. Co. KG, Withings SA, Welch Allyn Inc., SunTech Medical. Inc., A&D Medical, GE Healthcare
North America Wheelchair Accessible Vehicle Converters Market: Trends, Business Strategies and Opportunities with Key Players Analysis 2024
North America Wheelchair Accessible Vehicle Converters Market: Snapshot
The North America wheelchair accessible vehicle converters market has been displaying significant growth rate over the last few years, thanks to the increasing number of patients with disability. In the years to come, the market is likely to gain substantially from the rising demand for user-friendly accessible vehicles and the surge in the launch of affordable mobility gadgets. Apart from this, the mounting number of trauma cases, leading to disability and the escalating geriatric population is also expected to provide lucrative growth opportunities for the wheelchair accessible vehicle manufacturers in the near future.
In 2015, the North America market for wheelchair accessible vehicle converters was worth US$1.74 bn. According to researchers, the market’s future looks bright, rising at a CAGR of 5.30% from 2016 to 2024 and reaching US$3.47 bn by the end of 2024.
This 186 page report gives readers a comprehensive overview of the wheelchair accessible vehicle converters market. Browse through 38 data tables and 78 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/north-america-wheelchair-accessible-vehicle-converters-market.html
Full Size Vehicles to Continue as Leading Contributor to North America Market
On the basis of the type of vehicle, the North America market for wheelchair accessible vehicle converters has been classified into three broad categories, i.e., full size vehicles, medium size vehicles, and small size vehicles. Full size vehicles have been leading this market in terms of revenue; however, the demand for medium size vehicle is higher in North America. In 2015, the full size vehicle segment accounted for more than 48% of the overall market. With the increasing uptake of wheelchair accessible vehicles as family cars among families with disabled people, the revenue generated from this segment is likely to augment in the near future, ensuring its lead.
Based on the entry modality, the market has been categorized into ramps and lifts. The demand for ramps, which are mainly used for the medium size and small size vehicles, has been higher than lifts, which mostly find utilization in the case of a full size vehicle. The relatively low installation and maintenance costs of ramps have kept them a step ahead of lifts. The ramps segment led the North America wheelchair accessible vehicle converters market in 2015 with a share of 48.1%. Thanks to the ease of usage, ramps are expected to remain high in demand in this region over the next few years.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving wheelchair accessible vehicle converters market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16094
Demand from U.S. to Remain High
In terms of geography, the market for wheelchair accessible vehicle converters in North America has been segmented into the U.S. and Canada. With a share of nearly 95%, the U.S. led the overall market in 2015. The scenario is expected to remain so over the next few years, thanks to the presence of a large base of disabled population. The rising adoption of wheelchair accessible vehicles, stimulated by the increasing number of awareness initiatives by the manufacturers of vehicle converters, increasing cases of trauma resulting in disability, and the surge in the government funding for wheelchair accessible vehicles are also projected to boost the U.S. market for wheelchair accessible vehicle converters in the years to come.
The North America market for wheelchair accessible vehicle converters is fragmented and highly competitive in nature. Mobility Ventures LLC, Vantage Mobility International, and BraunAbility are at the forefront of this market. Some of the other prominent vendors of wheelchair accessible vehicle convertibles in this region are Toyota Motor Corp., Rollx Vans, and Freedom Motors USA.
Cell freezing or cryopreservation is the method of freezing tissues and cells at low temperatures to keep the biological material metabolically inert and genetically stable, and to reduce ice crystal formation. Ice crystals are smaller crystals of ice that form when the temperature is quite low and these can disrupt the cell membrane of the cell or tissue and can lead to death of cell. Cryopreservation is done to exchange some of the water cells with other compounds to reduce crystal formation. For cell freezing, various types of media or serum are used. The most common substitutes are glycerol and DMSO (dimethyl sulfoxide). Glycerol and dimethyl sulfoxide are mixed into a solution with serum or media in which cells are sited and suspended in a liquid nitrogen freezer. As media starts to freeze, the concentration of salt outside the cells become greater than the cells, and water leave the cells to exchange by cryopreservative.
Obtain Report Details: http://www.transparencymarketresearch.com/cell-freezing-media-market.html
Cell freezing media commonly comprises a protein source, base medium, and a cryopreservative. Cryopreservatives are used to protect the cells from physical stress, mechanical and diminishes the water content inside the cells, and minimizing the development of cell death or celllysing ice crystals. The protein source also protects the cells from the stress linked with the freeze-thaw process. Cells are frozen gradually, at one degree Celsius per minute, using techniques and programmable coolers.
The cell freezing media market has been segmented based on type of media and end-user. In terms of type of media, the cell freezing media market has been categorized into Chinese hamster ovary (CHO) cell Media, hybridoma media, insect media and vaccine production media. Chinese hamster ovary cells are capable of harvesting various recombinant glycoproteins at great levels on a big scale and have potential in pharmaceutical research and development and in bioprocessing. Hybridoma media is used in the development of monoclonal antibodies in cell culture system. Insect media is used for development of genetically engineered cell lines to express therapeutically valuable recombinant proteins. Insect media is a rapidly growing segment as it has created major breakthrough in health care. The vaccine production media is of various types such as classic media and salts, additional vaccine media, cell line media, fetal bovine serum (FBS), and other animal sera.
In terms of end-user, the cell freezing media market has been segmented into biopharmaceutical companies, pharmaceutical companies, and academics and research. Biopharmaceutical companies is the fast growing segment of the cell freezing media market owing to increasing research in the segment. Cell freezing media are used in pharmaceutical medicines for drug screening, formation of regenerative medicine, etc.
In terms of region, the cell freezing media market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to account for major share of the global cell freezing media market. Increasing research activities in North America and Europe for new drug development is anticipated to drive the cell freezing media market during the forecast period. Asia Pacific is the most progressive region for the cell freezing media market due to rising focus on bioprocessing and pharmaceutical research and development in countries such as Japan, China, and India.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20492
Increasing government initiatives for research in the pharmaceutical and biopharmaceutical segment is expected to fuel the growth of the cell freezing media market. Additionally, advantages of cell freezing for storage in drug development or in other programs are likely to fuel the growth of the market. However, high maintenance cost in storage procedure is the major factor that can hamper the growth of the market during the forecast period.
Major players in the cell freezing media market are Merck KGaA, Thermo Fisher Scientific, Inc., Nippon Genetics, Miltenyi Biotec, Mediatech, Inc., General Electric Company, BioLifeSolutions, Inc., HiMedia Laboratories, and PromoCell GmbH.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The global ulnar nerve entrapment market is prophesied by Transparency Market Research (TMR) to showcase a strong potential for a substantial growth in the foreseeable future. Bearing the title “Ulnar Nerve Entrapment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” a report by TMR prognosticates this growth to be fortified on the back of rising research and development investment made by pharmaceutical businesses. Furthermore, the introduction of novel technologies and products for treating ulnar nerve entrapment could hike up the demand in the market. Other factors such as elevating occurrences of vascular diseases are foreseen to positively impact the demand in the market.
Obtain Report Details: http://www.transparencymarketresearch.com/ulnar-nerve-entrapment-market.html
Conversely, there could be some factors impeding the growth of the world ulnar nerve entrapment market, such as restricted budget of small and medium-sized enterprises (SMEs) and long duration of treatments. Nevertheless, there could be opportunities springing up from the ignorance of the pain associated with the condition and high cost of surgery. Although the market for ulnar nerve entrapment could be in its emerging stage, vendors are expected to invite favorable prospects in the coming years.
Non-surgical and surgical could be two of the most popular treatments available in the world ulnar nerve entrapment market. Under non-surgical treatment, there could be more options, including splint and supporter devices, vitamin B6 supplement, non-steroidal anti-inflammatory drugs (NSAIDs), and medicines such as amitriptyline. The demand for ulnar nerve entrapment treatment could be projected to surge through key end users such as sports, chronic and acute care, ambulatory surgical clinics, and hospitals.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=27032
Out of all the important regions of the international ulnar nerve entrapment market, North America could take a leading position while riding on the business success in the U.S. The wild spread of chronic diseases and surging prevalence of other disorders are anticipated to be crucial factors improving the growth of the ulnar nerve entrapment market in the country. Having that mentioned, there could be other factors taking shape in the U.S. market, for instance, increasing research and development and invention of novel technologies. Asia Pacific, on the other hand, is envisaged to exhibit a faster growth in the market with a growing patient base and healthcare expanse in the limelight.
Some of the significant companies operating in the worldwide ulnar nerve entrapment market could be Amneal Pharmaceuticals LLC, Apotex, Inc., Teva Pharmaceutical Industries, Ltd., Alkem Laboratories, and Pfizer, Inc. With a view to secure a substantial share in the market, players are predicted to take to period launch of new products and variation in their existing products and services.